Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 July 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 185 pages)

 

Export 2278 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., “Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
V. Abbing-Karahagopian, Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C., Reynolds, R. F., and Klungel, O. H., “Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project”, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
K. M. Abel, Heatlie, H. F., Howard, L. M., and Webb, R. T., “Sex- and age-specific incidence of fractures in mental illness: a historical, population-based cohort study”, J Clin Psychiatry, vol. 69, pp. 1398-403, 2008.
K. M. Abel, Hope, H., Swift, E., Parisi, R., Ashcroft, D. M., Kosidou, K., Osam, C. S., Dalman, C., and Pierce, M., “Prevalence of maternal mental illness among children and adolescents in the UK between 2005 and 2017: a national retrospective cohort analysis”, Lancet Public Health, vol. 4, pp. e291-e300, 2019.
H. A. Abenhaim, Tulandi, T., Wilchesky, M., Platt, R., Spence, A. R., Czuzoj-Shulman, N., and Suissa, S., “Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction”, Obstet Gynecol, vol. 131, pp. 354-359, 2018.
F. N. Aberra, Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., and Lewis, J. D., “Antibiotic use and the risk of flare of inflammatory bowel disease”, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
F. N. Aberra, Stettler, N., Brensinger, C., Lichtenstein, G. R., and Lewis, J. D., “Risk for active tuberculosis in inflammatory bowel disease patients”, Clin Gastroenterol Hepatol, vol. 5, pp. 1070-5, 2007.
A. Abhishek, Nakafero, G., Kuo, C. F., Mallen, C., Zhang, W., Grainge, M. J., and Doherty, M., “Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 57, pp. 977-981, 2018.
A. Abhishek, Doherty, M., Kuo, C. F., Mallen, C. D., Zhang, W., and Grainge, M. J., “Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study”, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
D. Abrahami, Douros, A., Yin, H., Yu, O. H. Y., Renoux, C., Bitton, A., and Azoulay, L., “Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 360, p. k872, 2018.
D. Abrahami, Yin, H., Yu, O. H. Y., Pollak, M. N., and Azoulay, L., “Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes”, Epidemiology, vol. 29, pp. 246-253, 2018.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 363, p. k4880, 2018.
K. Abuabara, Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., and Gelfand, J. M., “Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K”, Br J Dermatol, vol. 163, pp. 586-92, 2010.
F. A. Achana, Fleming, K. M., Tata, L. J., Sultan, A. A., and Petrou, S., “Peripartum hysterectomy: an economic analysis of direct healthcare costs using routinely collected data”, Bjog, vol. 125, pp. 874-883, 2018.
R. Ackers, Murray, M. L., Besag, F. M., and Wong, I. C., “Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs”, Br J Clin Pharmacol, vol. 63, pp. 689-97, 2007.
R. Ackers, Besag, F. M., Wade, A., Murray, M. L., and Wong, I. C., “Changing trends in antiepileptic drug prescribing in girls of child-bearing potential”, Arch Dis Child, vol. 94, pp. 443-7, 2009.
R. Ackers, Besag, F. M., Hughes, E., Squier, W., Murray, M. L., and Wong, I. C., “Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research Database”, Drug Saf, vol. 34, pp. 403-13, 2011.
A. Afonso, Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., Souverein, P., Wang, Y., Korevaar, J. C., Hasford, J., Reynolds, R., de Groot, M. C., Schlienger, R., Klungel, O., and Rottenkolber, M., “A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction”, Eur J Clin Pharmacol, vol. 72, pp. 1105-16, 2016.
F. Ahmadizar, Souverein, P., de Boer, A., and van der Zee, A. H. Maitlan, “Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use”, Br J Clin Pharmacol, vol. 84, pp. 776-785, 2018.
H. Ahmed, Farewell, D., Francis, N. A., Paranjothy, S., and Butler, C. C., “Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data”, PLoS Med, vol. 15, p. e1002652, 2018.
F. O. Aina, Smeeth, L., Hubbard, R., Hurt, L. S., and Fletcher, A. E., “Hormone replacement therapy and cataract: a population-based case-control study”, Eye (Lond), vol. 20, pp. 417-22, 2006.
R. K. Akyea, Kai, J., Qureshi, N., Iyen, B., and Weng, S. F., “Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease”, Heart, 2019.
C. I. Alatorre, Hoogwerf, B. J., Deeg, M. A., Nelson, D. R., Hunter, T. M., Ng, W. T., and Rekhter, M. D., “Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control”, Curr Med Res Opin, vol. 34, pp. 337-343, 2018.
N. Al-Attar, Johnston, S., Jamous, N., Mistry, S., Ghosh, E., Gangoli, G., Danker, W., Etter, K., and Ammann, E., “Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England”, J Cardiothorac Surg, vol. 14, p. 64, 2019.
C. Alexakis, Saxena, S., Chhaya, V., Cecil, E., Curcin, V., and Pollok, R., “Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study”, Inflamm Bowel Dis, vol. 23, pp. 672-680, 2017.
M. Alexander, Ding, Y., Foskett, N., Petri, H., Wandel, C., and Khwaja, O., “Population prevalence of Down's syndrome in the United Kingdom”, J Intellect Disabil Res, vol. 60, pp. 874-8, 2016.
M. Alexander, Petri, H., Ding, Y., Wandel, C., Khwaja, O., and Foskett, N., “Morbidity and medication in a large population of individuals with Down syndrome compared to the general population”, Dev Med Child Neurol, vol. 58, pp. 246-54, 2016.
L. Alexandre, Clark, A. B., Bhutta, H. Y., Holt, S., Lewis, M. P., and Hart, A. R., “Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis”, Gastroenterology, vol. 146, pp. 661-8, 2014.
L. Alexandre, Clark, A. B., Bhutta, H. Y., Chan, S. S., Lewis, M. P., and Hart, A. R., “Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study”, Gastroenterology, vol. 150, pp. 854-65.e1; quiz e16-7, 2016.
K. Alexandropoulou, van Vlymen, J., Reid, F., Poullis, A., and Kang, J. Y., “Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study”, Eur J Gastroenterol Hepatol, vol. 25, pp. 15-21, 2013.
A. K. Ali, Hartzema, A. G., Winterstein, A. G., Segal, R., Lu, X., and Hendeles, L., “Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink”, Value Health, vol. 18, pp. 260-70, 2015.
V. Allan, Sammon, C. J., McDonald, L., Mehmud, F., Alikhan, R., and Ramagopalan, S. V., “Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink”, Future Cardiol, 2019.
C. Allen and Donegan, K., “The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 858-862, 2017.
A. Alonso, Jick, S. S., Olek, M. J., Ascherio, A., Jick, H., and Hernan, M. A., “Recent use of oral contraceptives and the risk of multiple sclerosis”, Arch Neurol, vol. 62, pp. 1362-5, 2005.
A. Alonso, Jick, S. S., and Hernan, M. A., “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
A. Alonso, Jick, S. S., Jick, H., and Hernan, M. A., “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
A. Alonso, Jick, S. S., Olek, M. J., and Hernan, M. A., “Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort”, J Neurol, vol. 254, pp. 1736-41, 2007.
A. Alonso, Rodriguez, L. A., Logroscino, G., and Hernan, M. A., “Gout and risk of Parkinson disease: a prospective study”, Neurology, vol. 69, pp. 1696-700, 2007.
A. Alonso, Logroscino, G., Jick, S. S., and Hernan, M. A., “Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study”, Eur J Neurol, vol. 16, pp. 745-51, 2009.
A. Alonso, Rodriguez, L. A., Logroscino, G., and Hernan, M. A., “Use of antidepressants and the risk of Parkinson's disease: a prospective study”, J Neurol Neurosurg Psychiatry, vol. 80, pp. 671-4, 2009.
A. Alonso, Logroscino, G., Jick, S. S., and Hernan, M. A., “Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study”, BMC Neurol, vol. 10, p. 6, 2010.
R. Alsaggaf, St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., Greene, M. H., Amr, S., and Gadalla, S. M., “Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity”, JNCI Cancer Spectr, vol. 2, p. pky052, 2018.
R. K. Amar, Jick, S. S., Rosenberg, D., Maher, T. M., and Meier, C. R., “Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis”, Respirology, vol. 17, pp. 861-8, 2012.
R. K. Amar, Jick, S. S., Rosenberg, D., Maher, T. M., and Meier, C. R., “Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008”, Respiration, vol. 84, pp. 200-6, 2012.
J. E. Amegadzie, Badejo, O., Gamble, J. M., Wright, M., Farrell, J., Jackson, B., Sultana, K., Hashmi, M., and Gao, Z., “Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol”, BMJ Open, vol. 9, p. e024306, 2019.
G. Amirthalingam, Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., and Ramsay, M., “Effectiveness of maternal pertussis vaccination in England: an observational study”, Lancet, vol. 384, pp. 1521-8, 2014.
F. Andersohn, Schade, R., Suissa, S., and Garbe, E., “Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study”, Stroke, vol. 37, pp. 1725-30, 2006.
F. Andersohn, Suissa, S., and Garbe, E., “Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction”, Circulation, vol. 113, pp. 1950-7, 2006.
F. Andersohn, Schade, R., Suissa, S., and Garbe, E., “Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus”, Am J Psychiatry, vol. 166, pp. 591-8, 2009.
F. Andersohn, Schade, R., Willich, S. N., and Garbe, E., “Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior”, Neurology, vol. 75, pp. 335-40, 2010.
[Page last reviewed 4 July 2019]